Product Information
GENTAMICIN 0.1% OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.9407 per GM under NDC 45802004635. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Feb 18, 1982. Its Orange Book therapeutic-equivalence code is AT.
Strength
1 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802004635
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
GENTAMICIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA062351FDA Approved
2/18/1982
TE Code
AT
On Market Since
7/10/2006
Pharmacological Classes
Price Statistics
The NADAC for GENTAMICIN 0.1% OINTMENT has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 22.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9407 per GM |
|---|---|
| All-time high | $2.5527 (Sep 14, 2016) |
| All-time low | $0.6202 (Nov 20, 2024) |
| 52-week high | $1.0778 |
| 52-week low | $0.9090 |
| Median price | $1.6079 |
| Average price | $1.6798 |
| Largest weekly change | -48.7% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Gentamicin Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GENTAMICIN 0.1% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for GENTAMICIN 0.1% OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.9407 per GM (NDC 45802004635), effective Sep 30, 2026.
How has the price of GENTAMICIN 0.1% OINTMENT changed over time?
Over the history we have for it, the NADAC for GENTAMICIN 0.1% OINTMENT has risen 22.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GENTAMICIN 0.1% OINTMENT?
Since Nov 28, 2013, the NADAC for GENTAMICIN 0.1% OINTMENT has ranged from a low of $0.6202 (Nov 20, 2024) to a high of $2.5527 (Sep 14, 2016), with a median of $1.6079 per GM.
Are there cheaper alternatives to GENTAMICIN 0.1% OINTMENT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GENTAMICIN 0.1% OINTMENT, is $0.7705 per GM — about 18% below GENTAMICIN 0.1% OINTMENT.
Who manufactures GENTAMICIN 0.1% OINTMENT?
GENTAMICIN 0.1% OINTMENT (NDC 45802004635) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.